Related Experiment Video
Updated: Jun 25, 2026

10:07
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Metal-Organic Framework as a Bioorthogonal Catalyst for Gene Editing
Ziyi Chen1, Xingyu Liu1, Wanyue Sang2
1Key Laboratory of Biomedical Polymers Ministry of Education, College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China.
Journal of the American Chemical Society
|June 24, 2026
Summary
Researchers engineered metal-organic frameworks (MOFs) with precise catalytic pores for bioorthogonal RNA manipulation in cells. These MOFs enable controlled RNA reactions and gene editing regulation, offering new therapeutic strategies.
Area of Science:
- Materials Science
- Chemical Biology
- Biotechnology
Background:
- Metal-organic frameworks (MOFs) offer tunable structures for various applications.
- Bioorthogonal chemistry enables reactions within living systems without interference.
- RNA manipulation is crucial for gene editing and disease treatment.
Purpose of the Study:
- To design MOFs with molecularly defined catalytic pores for bioorthogonal RNA manipulation.
- To investigate the influence of MOF structural precision on RNA recognition and conversion.
- To develop MOF-based catalysts for intracellular RNA reactions and therapeutic applications.
Main Methods:
- Reticular design and synthesis of MOF libraries with varied Cu cluster geometries and pore dimensions.
- Small-angle X-ray scattering (SAXS) to study substrate positioning within MOF pores.
- Synchrotron soft X-ray microscopy for visualizing intracellular MOF localization and integrity.
- In vitro and in vivo experiments for RNA cleavage, formation, and gene editing regulation.
Main Results:
- MOFs with dimensionally matched mesopores and Cu(I) clusters efficiently catalyzed RNA bond cleavage and formation in living systems.
- Pore chemistry was found to govern substrate positioning, enhancing RNA engagement and product release for complete conversion.
- Intracellular visualization confirmed MOF integrity and bioorthogonal catalytic activity.
- An amine-functionalized MOF (MOF-248-NH2) demonstrated controlled sgRNA activation for CRISPR/Cas9 gene editing and cardiac disease treatment in a canine model.
Conclusions:
- Reticular pore engineering is a powerful strategy for creating programmable bioorthogonal MOF catalysts.
- MOFs can be designed for precise control over RNA manipulation within living cells.
- This approach holds significant potential for advancing gene editing technologies and developing novel therapeutics.
